Currently, common treatments for adenomyosis include GnRH agonists (2–4), danazol (5), aromatase inhibitors (6), and levonorgestrel-releasing intrauterine devices (6, 7), but symptoms recur after withdrawal and require long-term medication. The gene discussed is GNRH1; the disease is adenomyosis.